What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Seppo Ylä-Herttuala focuses on Immunology, Angiogenesis, Vascular endothelial growth factor, Internal medicine and Vascular endothelial growth factor C.
His work deals with themes such as Clinical trial, In situ hybridization and Cell biology, which intersect with Immunology.
His Angiogenesis research is multidisciplinary, relying on both Endothelium and Growth factor.
Seppo Ylä-Herttuala interconnects Autoantibody, Endocrinology, Surgery and Cardiology in the investigation of issues within Internal medicine.
His study looks at the relationship between Endocrinology and topics such as Antibody, which overlap with Molecular biology and Staining.
The various areas that Seppo Ylä-Herttuala examines in his Vascular endothelial growth factor C study include Vascular endothelial growth factor B, Lymphatic system and Vascular Endothelial Growth Factor D, Lymphangiogenesis.
His most cited work include:
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. (1721 citations)
- Low density lipoprotein undergoes oxidative modification in vivo (1365 citations)
- Autoantibody against oxidised LDL and progression of carotid atherosclerosis. (1215 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Genetic enhancement, Pathology, Angiogenesis and Molecular biology.
The study incorporates disciplines such as Endocrinology and Cardiology in addition to Internal medicine.
His Genetic enhancement research integrates issues from Cancer research, Clinical trial, Bioinformatics and Viral vector.
His Pathology research is multidisciplinary, incorporating perspectives in Inflammation and Lymphangiogenesis.
His Angiogenesis study combines topics in areas such as Vascular endothelial growth factor A, Vascular endothelial growth factor, Immunology and Cell biology.
In his work, Glioma is strongly intertwined with In vivo, which is a subfield of Molecular biology.
He most often published in these fields:
- Internal medicine (24.12%)
- Genetic enhancement (20.02%)
- Pathology (16.59%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (24.12%)
- Angiogenesis (15.15%)
- Genetic enhancement (20.02%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Angiogenesis, Genetic enhancement, Cancer research and Cell biology.
His studies deal with areas such as Endocrinology and Cardiology as well as Internal medicine.
His study in Angiogenesis is interdisciplinary in nature, drawing from both Vascular endothelial growth factor A, Vascular endothelial growth factor, Kinase insert domain receptor, Lymphangiogenesis and Ovarian cancer.
His Genetic enhancement research is multidisciplinary, incorporating elements of Viral vector, Clinical trial, Adeno-associated virus and Pharmacology.
The various areas that he examines in his Cancer research study include Bladder cancer and Cell type.
In his study, Enhancer is inextricably linked to Transcriptional regulation, which falls within the broad field of Cell biology.
Between 2016 and 2021, his most popular works were:
- Consensus guidelines for the use and interpretation of angiogenesis assays (194 citations)
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice (163 citations)
- Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain (135 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Seppo Ylä-Herttuala spends much of his time researching Internal medicine, Angiogenesis, Pathology, Cell biology and Cancer research.
Seppo Ylä-Herttuala combines subjects such as Endocrinology, Magnetic resonance imaging and Cardiology with his study of Internal medicine.
His Angiogenesis study incorporates themes from Extracellular matrix, KRAS, Kinase insert domain receptor and Gene delivery.
His Pathology research includes themes of Inflammation, Positron emission tomography, Mutation and Somatic cell.
His biological study spans a wide range of topics, including Chromatin, Cohesin, Transcription factor and microRNA.
His work on Vascular endothelial growth factor A and Vascular endothelial growth factor as part of general Cancer research research is frequently linked to Histone code, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
